HLA-C and melanoma: In agreement with the HLA-C mismatching and KIR-Ligand mismatching models [20], [22], melanoma cells were more efficiently killed by allogeneic NK cells derived from HLA-C mismatched donors, as compared to the HLA-C matched NK cells (Figure 2A).